| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |